Crohn's
Salix And Alfasigma Will Initiate Late-Stage Program To Study Rifaximin In Patients With Postoperative Crohn's Disease
Bausch Health Companies Inc.
PR-M10-18-NI-106Oct 31, 2018
Real World Data
New Real-World Data Analyses Support the Long-Term Use of Entyvio® (vedolizumab) in Bio-Naïve Patients for the Treatment of Moderate to Severe Ulcerative Colitis or Crohn's Disease
Takeda
PR-M10-18-NI-034Oct 10, 2018